Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 15, 2015 - Issue 6
Submit an article Journal homepage
1,487
Views
4
CrossRef citations to date
0
Altmetric
Editorials

Incorporating real-world clinical practice in multiple sclerosis economic evaluations

R Brett McQueenUniversity of Colorado Anschutz Medical Campus - Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 E. Montview Blvd Aurora, Aurora, CO 80045, USACorrespondence[email protected]
,
Kavita V NairUniversity of Colorado Anschutz Medical Campus - Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 E. Montview Blvd Aurora, Aurora, CO 80045, USA
,
Timothy L VollmerUniversity of Colorado Anschutz Medical Campus – Neurology, Aurora, CO, USA
&
Jonathan D CampbellUniversity of Colorado Anschutz Medical Campus - Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 E. Montview Blvd Aurora, Aurora, CO 80045, USA
Pages 869-872 | Published online: 20 Aug 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sirin Gandhi, Dejan Jakimovski, Rahil Ahmed, David Hojnacki, Channa Kolb, Bianca Weinstock-Guttman & Robert Zivadinov. (2016) Use of natalizumab in multiple sclerosis: current perspectives. Expert Opinion on Biological Therapy 16:9, pages 1151-1162.
Read now

Articles from other publishers (3)

Anggie Wiyani, Lohit Badgujar, Vivek Khurana & Nicholas Adlard. (2021) How have Economic Evaluations in Relapsing Multiple Sclerosis Evolved Over Time? A Systematic Literature Review. Neurology and Therapy 10:2, pages 557-583.
Crossref
Mieko Ogino, Shuichi Okamoto, Hiroyuki Ohta, Mariko Sakamoto, Yusuke Nakamura, Kosuke Iwasaki, Manami Yoshida, Shinzo Hiroi & Izumi Kawachi. (2017) Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database. Clinical and Experimental Neuroimmunology 8:4, pages 318-326.
Crossref
M. Moccia, R. Palladino, R. Lanzillo, M. Triassi & V. Brescia Morra. (2017) Predictors of the 10-year direct costs for treating multiple sclerosis. Acta Neurologica Scandinavica 135:5, pages 522-528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.